Business
AIML Innovations Announces Departure of Tim Daniels from Board of Directors
• Tim Daniels to Continue Supporting AIML in an Advisory Capacity VANCOUVER, BC / AC...
About this update from Aiml Innovations Inc
[{"type":"text","content":"AIML Innovations Announces Departure of Tim Daniels from Board of Directors• Tim Daniels to Continue Supporting AIML in an Advisory Capacity VANCOUVER, BC / ACCESS Newswire / April 25, 2025 / AI/ML INNOVATIONS INC. (\"AIML\" OR THE \"COMPANY\") (CSE:AIML)(OTCQB:AIMLF)(FWB:42FB) announces that Tim Daniels has stepped down from his position on the Company's Board of Directors (\"Board\"), effective immediately.Tim has been an integral part of AIML's leadership, contributing to the Company's strategic direction and governance during his tenure on the Board. His insights and dedication have played a key role in guiding AIML through important phases of growth and evolution.Paul Duffy, CEO of AIML, commented:\"On behalf of the entire team at AIML, I would like to extend our sincere thanks to Tim for his contributions and leadership. We are pleased that Tim will continue to support the Company in an advisory capacity, where his experience and counsel will remain a valued asset as we advance our mission in AI-driven healthcare.\"AIML remains focused on strengthening its leadership and advisory network to support ongoing commercialization efforts and strategic growth initiatives.For more information about AIML:For detailed information please see AIML's website or the Company's filed documents at www.sedarplus.ca.Contact:Blake Fallis(778) [email protected] AI/ML Innovations Inc. https://aiml-innovations.com/AIML Innovations Inc. has realigned its business operations to capitalize on the burgeoning fields of artificial intelligence: (AI) and machine learning (ML), with an initial investment focus on emerging digital health and wellbeing companies that leverage AI, ML, cloud computing and digital platforms to drive transformative healthcare management solutions and precision support delivery across the health continuum. Through its wholly owned subsidiaries, NeuralCloud Solutions Inc, Quantum Sciences Ltd, and AI Rx Inc., strategic partnerships with Health Gauge Inc. (95.2% owned by AIML), and other planned accretive investments, the Company continues to capitalize on expanding growth areas, to the benefit of all the Company's stakeholders. AIML's shares are traded on the Canadian Securities Exchange under the symbol \"AIML\", the OTCQB Venture Market under \"AIMLF\", and the Frankfurt Stock Exchange under \"42FB...